Conmed Aktie
WKN: 886793 / ISIN: US2074101013
31.07.2025 04:28:55
|
Conmed Corp. Q2 Profit Decreases, But Beats Estimates
(RTTNews) - Conmed Corp. (CNMD) announced earnings for second quarter that Decreased from the same period last year but beat the Street estimates.
The company's bottom line came in at $21.42 million, or $0.69 per share. This compares with $29.98 million, or $0.96 per share, last year.
Excluding items, Conmed Corp. reported adjusted earnings of $35.61 million or $1.15 per share for the period.
Analysts on average had expected the company to earn $1.12 per share. Analysts' estimates typically exclude special items.
The company's revenue for the period rose 3.1% to $342.35 million from $332.10 million last year.
Conmed Corp. earnings at a glance (GAAP) :
-Earnings: $21.42 Mln. vs. $29.98 Mln. last year. -EPS: $0.69 vs. $0.96 last year. -Revenue: $342.35 Mln vs. $332.10 Mln last year.
-Guidance: Full year EPS guidance: $4.40 to $4.55 Full year revenue guidance: $1.356 B to $1.378 B
The company raised its full-year 2025 adjusted net earnings per share outlook to a range of $4.40 to $4.55 from the prior estimation of $4.31 to $4.46.
The company now projects full-year revenue to be between $1.356 billion and $1.378 billion, compared to the prior guidance $1.350 billion to $1.378 billion.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Conmed Corp.mehr Nachrichten
29.07.25 |
Ausblick: Conmed veröffentlicht Zahlen zum vergangenen Quartal (finanzen.net) | |
15.07.25 |
Erste Schätzungen: Conmed verkündet Quartalsergebnis zum jüngsten Jahresviertel (finanzen.net) | |
29.04.25 |
Ausblick: Conmed informiert über die jüngsten Quartalsergebnisse (finanzen.net) | |
15.04.25 |
Erste Schätzungen: Conmed stellt Zahlen zum jüngsten Quartal vor (finanzen.net) |
Analysen zu Conmed Corp.mehr Analysen
Aktien in diesem Artikel
Conmed Corp. | 40,20 | 3,08% |
|